Cite
HARVARD Citation
Rodler, E. et al. (2023). Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet oncology. 24 (2), pp. 162-174. [Online].